[ 鐧诲綍] [ 鍏嶈垂娉ㄥ唽]
璇曞墏浠櫒缃? title=
浣嶇疆锛欬a href="/">棣栭〉> 浜у搧搴掽/a> > Probenecid-d14
绔嬪嵆鍜ㄨ
鍜ㄨ绫诲瀷锛欬/div>
*濮撳悕锛欬/div>
*鐢佃瘽锛欬/div>
*鍗曚綅锛欬/div>
Email锛欬/div>
*鐣欒█鍐呭锛欬/div>
璇疯缁嗚鏄庢偍鐨勯渶姹傘€
*楠岃瘉鐮侊細
Probenecid-d14
鏈骇鍝佷笉鍚戜釜浜洪攢鍞紝浠呯敤浣滅瀛︾爺绌讹紝涓嶇敤浜庝换浣曚汉浣撳疄楠屽強闈炵鐮旀€ц川鐨勫姩鐗╁疄楠屻€侟/div>
Probenecid-d14鍥剧墖
CAS NO: 1189657-87-1
瑙勬牸: 98%
鍒嗗瓙閲廁 299.4
鍖呰涓庝环鏍硷細
鍖呰 浠锋牸(鍏?
1mg 鐢佃
5mg 鐢佃

浜у搧浠嬬粛
Probenecid-d14 is intended for use as an internal standard for the quantification of probenecid by GC- or LC-MS.
CAS锛?189657-87-1
鍒嗗瓙寮忥細C13H5D14NO4S
鍒嗗瓙閲忥細299.4
绾害锛?8%
瀛樺偍锛歋tore at -20掳C

Background:

Probenecid-d14 is intended for use as an internal standard for the quantification of probenecid by GC- or LC-MS. Probenecid is a benzoic acid derivative that inhibits organic anion transporters (OATs) but activates the transient receptor potential (TRP) channel TRPV2. It inhibits OAT1, OAT3, and OAT6 with Ki values of 6.3, 9.0, and 8.4 ?M, respectively, as well as OAT2 with an IC50 value of 0.67 ?M. It is a poor inhibitor of the organic cation transporters OCT1 and OCT2 (IC50 = 1.6 and 1.7 mM, respectively). It also acts as an agonist of TRPV2 (EC50 = 31.9 ?M), eliciting nociceptive behavior under inflammatory conditions in mice. Formulations containing probenecid have been used in the treatment of gouty arthritis.


Baidu
map